carditis have been found on necropsy in as many as 30-50% of patients with SLE, particularly in the presteroid era, these lesions frequently were unrecognized clinically. However, with the widespread availability of two-dimensional echocardiography and the more recent development of Doppler echocardiography and color flow imaging, the premortem recognition of valvular disease in patients with SLE has become considerably more frequent.12-16 A recent echocardiographic report of 74 patients with SLE15 indicated an overall prevalence of clinically important valvular disease in 18%. The report also recognized a "subset" of SLE patients with valvular thickening often associated with regurgitation or stenosis in addition to those with verrucous endocarditis.15
Antiphospholipid Antibodies
The sera of patients with SLE contain many antibodies that react with native or altered autologous antigens; these include antibodies to nuclear components; antibodies to cell surface and cytoplasmic antigens of lymphocytes, polymorphonuclear cells, red blood cells, platelets, and neuronal cells; and antibodies to IgG and IgM. [17] [18] [19] [20] It is uncertain whether any of these autoantibodies are pathogenic per se or whether they merely serve as "markers" or "epiphenomena" to not-yet-elaborated basic immunologic abnormalities in particular subsets of SLE patients. An antigen-antibody reaction likely to affect the cardiac conduction system is suggested by the finding of ribonucleoprotein antibodies in both the sera of mothers with SLE and their affected infants with congenital complete atrioventicular block.21
A recently defined group of antiphospholipid antibodies are found in increased serum concentrations in many patients with SLE,17-20,22 including the lupus "anticoagulant," antibodies to IgG and IgM cardiolipin, and the false-positive test (VDRL) for syphilis. The antiphospholipid syndrome includes venous and arterial thromboses, recurrent spontaneous abortion, thrombocytopenia, livedo reticularis, and labile hypertension. While occurring most often in patients with SLE, the clinical complex also occurs in "nonlupus" patients who have some features of connective tissue disease and in patients with a "primary" antiphospholipid syndrome. 
